The Office of Generic Drugs started to send out official correspondence saying that an amendment submitted without a verification statement is deficient, because it is not reflecting a new ANDA section of Code of Federal Regulations - 21 CFR 314.96(d). This regulation states as follows:
a) To add a new indication or other condition of use;
b) To add a new strength;
c) To make other than minor changes in product formulation; or
d) To change the physical form or crystalline structure of the active ingredient.
If the amendment to the ANDA does not contain a patent certification or statement, the applicant must verify that the proposed change described in the amendment is not one of the types of amendments described above.
El equipo de investigadores observó cambios en el...
El gen AtCDF3 promueve una mayor producción de az...
Un estudio con datos de los últimos 35 años, ind...
En nuestro post hablamos sobre este interesante tipo de célula del si...
La revista ‘Nature Protocols’ selecciona esta técnica como “pro...
Portal de biotecnología en España
¡Suscríbase a nuestro newsletter para estar al día con las últimas noticias y ofertas!
2013 © Biotech-Spain.com - Site Developments SL. Todos los derechos reservados. Terminos y Condiciones | Política de Privacidad
Articles
Directory